Levosimendan and severe pulmonary hypertension during open heart surgery

General Thoracic and Cardiovascular Surgery

Volumn 56, Issue 11, 2008, Pages 563-565

  Cicekcioglu, Ferit ^a   Parlar, Ali Ihsan ^a   Ersoy, Ozgur ^a   Yay, Kerem ^a   Hijazi, Alaa ^a   Katircioglu, S Fehmi ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

Levosimendan; Preconditioning; Pulmonary hypertension; Valve repair replacement

Indexed keywords

LEVOSIMENDAN;

ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; HEART INFARCTION PREVENTION; ISCHEMIC PRECONDITIONING; LUNG ARTERY PRESSURE; MITRAL VALVE; OPEN HEART SURGERY; PULMONARY HYPERTENSION; SURGICAL PATIENT; THERAPY EFFECT; TREATMENT RESPONSE; VALVULAR HEART DISEASE; VASODILATATION; WEANING;

CARDIAC SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYDRAZONES; HYPERTENSION, PULMONARY; MIDDLE AGED; PYRIDAZINES; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 56049091269     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-008-0301-4     Document Type: Article

References (10)

1. J.J. Vincens D. Temizer J.R. Post L.H. Edmunds Jr 1995 Herrmann HC. Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension Circulation 92 137 142
2. + channel in rat arterial myocytes Eur J Pharmacol 333 249 259
3. W.G. Toller C. Stranz 2006 Levosimendan, a new inotropic and vasodilator agent Anesthesiology 104 556 569
4. A.D. Michaels B. McKeown M. Kostal K.T. Vakharia M.V. Jordan I.L. Gerber 2005 Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake Circulation 111 1504 1509
5. B.J. De Witt I.N. Ibrahim E. Bayer A.M. Fields T.A. Richards R.E. Banister 2002 An analysis of responses to levosimendan in the pulmonary vascular bed of the cat Anesth Analg 94 1427 1433
6. J. Pataricza I. Krassoi J. Hohn A. Kun J.G. Papp 2003 Functional role of potassium channels in the vasodilating mechanism of levosimendan in porcine isolated coronary artery Cardiovasc Drugs Ther 17 115 121
7. H. Yokoshiki N. Sperelakis 2003 Vasodilating mechanisms of levosimendan Cardiovasc Drugs Ther 17 111 113
8. P. Bowman H. Haikala R.J. Paul 1999 Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization J Pharmacol Exp Ther 288 316 325
9. H. Haikala I.B. Linden 1995 Mechanisms of action of calcium-sensitizing drugs J Cardiovasc Pharmacol 26 suppl1 S10 S9
10. M. Westphal A. Morelli H. Van Aken 2007 Dear levosimendan, the right ventricle will thank you! Crit Care Med 35 952 953